Survivin: a new player during erythroblast maturationNUNOMURA, Wataru; SAWADA, Kenichi.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1456-1458, issn 0390-6078, 3 p.Article

The Inhibitor of Apoptosis Protein Livin (ML-IAP) Plays a Dual Role in TumorigenicityABD-ELRAHMAN, Ihab; HERSHKO, Klilah; NEUMAN, Tzahi et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 13, pp 5475-5480, issn 0008-5472, 6 p.Article

A Survivin-Associated Adaptive Response in Radiation TherapyGRDINA, David J; MURLEY, Jeffrey S; MILLER, Richard C et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 14, pp 4418-4428, issn 0008-5472, 11 p.Article

A novel role for survivin in erythroblast enucleationKEERTHIVASAN, Ganesan; HUI LIU; GUMP, Jacob M et al.Haematologica (Roma). 2012, Vol 97, Num 10, pp 1471-1479, issn 0390-6078, 9 p.Article

Survivin is not required for the endomitotic cell cycle of megakaryocytesQIANG WEN; LEUNG, Cindy; ZAN HUANG et al.Blood. 2009, Vol 114, Num 1, pp 153-156, issn 0006-4971, 4 p.Article

Cancer cells survive with survivinYAMAMOTO, Hirofumi; CHEW YEE NGAN; MONDEN, Morito et al.Cancer science. 2008, Vol 99, Num 9, pp 1709-1714, issn 1347-9032, 6 p.Article

The inhibitor of apoptosis proteins as therapeutic targets in cancerVUCIC, Domagoj; FAIRBROTHER, Wayne J.Clinical cancer research. 2007, Vol 13, Num 20, pp 5995-6000, issn 1078-0432, 6 p.Article

The universal character of the tumor-associated antigen survivinHALD ANDERSEN, Mads; MARIE SVANE, Inge; BECKER, Jurgen C et al.Clinical cancer research. 2007, Vol 13, Num 20, pp 5991-5994, issn 1078-0432, 4 p.Article

Mcl-1 and Bel-x_L coordinately regulate megakaryocyte survivalDEBRINCAT, Marlyse A; JOSEFSSON, Emma C; ROBERTS, Andrew W et al.Blood. 2012, Vol 119, Num 24, pp 5850-5858, issn 0006-4971, 9 p.Article

N-α-Acetyltransferase 10 protein inhibits apoptosis through Re1A/p65-regulated MCL1 expressionHUIYU XU; BEIHAI JIANG; LIN MENG et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 6, pp 1193-1202, issn 0143-3334, 10 p.Article

Survivin-3B Potentiates Immune Escape in Cancer but Also Inhibits the Toxicity of Cancer ChemotherapyVEGRAN, Frédérique; MARY, Romain; GIBEAUD, Anne et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 17, pp 5391-5401, issn 0008-5472, 11 p.Article

miR-193b Regulates Mcl-1 in MelanomaJIAMIN CHEN; XIAO ZHANG; LENTZ, Cindy et al.The American journal of pathology. 2011, Vol 179, Num 5, pp 2162-2168, issn 0002-9440, 7 p.Article

Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose StudyTALBOT, Denis C; RANSON, Malcolm; MCHUGH, Peter J et al.Clinical cancer research (Print). 2010, Vol 16, Num 24, pp 6150-6158, issn 1078-0432, 9 p.Article

Survivin expression in the bone marrow of patients with severe congenital neutropeniaCARLSSON, G; BOXHAMMER, S; GARWICZ, D et al.Leukemia. 2009, Vol 23, Num 3, pp 622-625, issn 0887-6924, 4 p.Article

Nuclear Survivin Abrogates Multiple Cell Cycle Checkpoints and Enhances Viral OncolysisCONNELL, Claire M; WHEATLEY, Sally P; MCNEISH, Iain A et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 19, pp 7923-7931, issn 0008-5472, 9 p.Article

Survivin Mediates Renal Proximal Tubule Recovery from AKIJIANCHUN CHEN; CHEN, Jian-Kang; CONWAY, Edward M et al.Journal of the American Society of Nephrology. 2013, Vol 24, Num 12, pp 2023-2033, issn 1046-6673, 11 p.Article

Survivin and escaping in therapy-induced cellular senescenceQIN WANG; WU, Peter C; ROBERSON, Rachel S et al.International journal of cancer (Print). 2011, Vol 128, Num 7, pp 1546-1558, issn 0020-7136, 13 p.Article

Mcl-1 : A Gateway to TRAIL SensitizationKIM, Seok-Hyun; STACEY RICCI, M; EL-DEIRY, Wafik S et al.Cancer research (Baltimore). 2008, Vol 68, Num 7, pp 2062-2064, issn 0008-5472, 3 p.Article

Treat cancers by targeting survivin: Just a dream or future reality?MOHANE SELVARAJ COUMAR; TSAI, Fang-Ying; JAGAT RAKESH KANWAR et al.Cancer treatment reviews. 2013, Vol 39, Num 7, pp 802-811, issn 0305-7372, 10 p.Article

The survivin suppressants NSC 80467 and YM155 induce a DNA damage responseGLAROS, Trevor G; STOCKWIN, Luke H; MULLENDORE, Michael E et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 1, pp 207-212, issn 0344-5704, 6 p.Article

Inhibitor of apoptosis proteins in hematological malignanciesFULDA, S.Leukemia. 2009, Vol 23, Num 3, pp 467-476, issn 0887-6924, 10 p.Article

Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial CellsVIRREY, Jenilyn J; SHENGXI GUAN; WEI LI et al.The American journal of pathology. 2008, Vol 173, Num 2, pp 575-585, issn 0002-9440, 11 p.Article

Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of SurvivinTOLCHER, Anthony W; MITA, Alain; KEATING, Anne et al.Journal of clinical oncology. 2008, Vol 26, Num 32, pp 5198-5203, issn 0732-183X, 6 p.Article

T-Cell Responses to Survivin in Cancer Patients Undergoing Radiation TherapySCHAUE, Dörthe; COMIN-ANDUIX, Begonya; RIBAS, Antoni et al.Clinical cancer research (Print). 2008, Vol 14, Num 15, pp 4883-4890, issn 1078-0432, 8 p.Article

Utility of P-Glycoprotein and Organic Cation Transporter 1 Double-Transfected LLC-PK1 Cells for Studying the Interaction of YM155 Monobromide, Novel Small-Molecule Survivin Suppressant, with P-GlycoproteinIWAI, Megumi; MINEMATSU, Tsuyoshi; QUN LI et al.Drug metabolism and disposition. 2011, Vol 39, Num 12, pp 2314-2320, issn 0090-9556, 7 p.Article